# Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients

> **NCT01148576** · PHASE4 · UNKNOWN · sponsor: **Zhejiang University** · enrollment: 1200 (estimated)

## Conditions studied

- Chronic Hepatitis B
- Hepatic Steatosis

## Interventions

- **DRUG:** entecavir
- **DRUG:** entecavir
- **DRUG:** essentiale + entecavir
- **DRUG:** Vitamin E + entecavir

## Key facts

- **NCT ID:** NCT01148576
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2010-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148576, "Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01148576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*